Polyethylene oxide and its controlled release properties in hydrophilic matrix tablets for oral administration

References

• Antioxidant Use in POLYOX™ ER Matrices, Technical Data, POLYOXTM Water Soluble Resins, Colorcon.
   Google Scholar
• Antioxidant Use in POLYOX™ ER Matrices. Application Data. POLYOXTM Water Soluble Resins. Colorcon. 2009.
   Google Scholar
• Apicella A, Cappello B, Del Nobile M, La Rotonda M, Mensitieri G, Nicolais L. 1993. Poly(ethylene oxide) (PEO) and different molecular weight PEO blends monolithic devices for drug release. Biomaterials. 14(2):83–90.
   PubMed Web of Science ®Google Scholar
• Bailey FJ. 2012. Poly (ethylene oxide). New York: Elsevier.
   Google Scholar
• Balamurugan J, Vijayalakshmi P. 2014. Preparation and evaluation of floating extended release matrix tablet using combination of polymethacrylates and polyethylene oxide polymers. Int J Pharm Pharm Sci. 6(8):584–592.
   Google Scholar
• Bansal AK, Balwani G, Sheokand S. 2019. Critical material attributes in wet granulation. In: Narang A, Badawy S, editors. Handbook of pharmaceutical wet granulation. 1st ed. New York (NY): Academic Press; p. 421–453.
   Google Scholar
• Berner B, Chen C. 2015. Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract. Google Patents.
   Google Scholar
• Bettini R, Catellani P, Santi P, Massimo G, Peppas N, Colombo P. 2001. Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate. J Control Release. 70(3):383–391.
   PubMed Web of Science ®Google Scholar
• Bieze T, Barnes A, Huige C, Enderby J, Leyte J. 1994. Distribution of water around poly (ethylene oxide): a neutron diffraction study. J Phys Chem. 98(26):6568–6576.
   Web of Science ®Google Scholar
• Caccavo D, Cascone S, Lamberti G, Barba AA. 2015. Controlled drug release from hydrogel-based matrices: experiments and modeling. Int J Pharm. 486(1–2):144–152.
   PubMed Web of Science ®Google Scholar
• Cantin O, Siepmann F, Danede F, Willart J, Karrout Y, Siepmann J. 2016. PEO hot melt extrudates for controlled drug delivery: importance of the molecular weight. J Drug Deliv Sci Technol. 36:130–140.
   Web of Science ®Google Scholar
• Casettari L, Bonacucina G, Cespi M, Perinelli D, Micheli M, Cacciatore I, Di Stefano A, Palmieri G. 2016. Effect of manufacturing temperature and molecular weights on compression, mechanical and dissolution properties of PEO matrix tablets. J Drug Deliv Sci Technol. 32:236–240.
   Web of Science ®Google Scholar
• Chaudhari Shilpa Pravin PPS, Ratnaparkhi Mukesh P. 2013. Formulation development and evaluation of sustained release matrix tablet of zidovudine. Am J Adv Drug Del. 1(5):691–705.
   Google Scholar
• Cheng K, Zhu J, Song X, Sun L, Zhang J. 1999. Studies of hydroxypropyl methylcellulose donut-shaped tablets. Drug Dev Ind Pharm. 25(9):1067–1071.
   PubMed Web of Science ®Google Scholar
• Cheng XX, Qi X, Zhang G, Dixit M. 2014. Diltiazem controlled release formulation and method of manufacture. Google Patents.
   Google Scholar
• Choi DH, Kim KH, Park JS, Jeong SH, Park K. 2013. Evaluation of drug delivery profiles in geometric three-layered tablets with various mechanical properties, in vitro–in vivo drug release, and Raman imaging. J Control Release. 172(3):763–772.
   PubMed Web of Science ®Google Scholar
• Choi S-U, Lee J, Wook Choi Y. 2003. Development of a directly compressible poly (ethylene oxide) matrix for the sustained-release of dihydrocodeine bitartrate. Drug Dev Ind Pharm. 29(10):1045–1052.
   PubMed Web of Science ®Google Scholar
• Colby RH, Fetters LJ, Graessley WW. 1987. The melt viscosity-molecular weight relationship for linear polymers. Macromolecules. 20(9):2226–2237.
   Web of Science ®Google Scholar
• Colombo P, Bettini R, Catellani PL, Santi P, Peppas NA. 1999a. Drug volume fraction profile in the gel phase and drug release kinetics in hydroxypropylmethyl cellulose matrices containing a soluble drug. Eur J Pharm Sci. 9(1):33–40.
   PubMed Web of Science ®Google Scholar
• Colombo P, Bettini R, Peppas NA. 1999b. Observation of swelling process and diffusion front position during swelling in hydroxypropyl methyl cellulose (HPMC) matrices containing a soluble drug. J Control Release. 61(1–2):83–91.
   PubMed Web of Science ®Google Scholar
• Colombo P, Bettini R, Santi P, Peppas NA. 2000. Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. Pharm Sci Technol Today. 3(6):198–204.
   PubMedGoogle Scholar
• Crowley MM, Zhang F, Koleng JJ, McGinity JW. 2002. Stability of polyethylene oxide in matrix tablets prepared by hot-melt extrusion. Biomaterials. 23(21):4241–4248.
   PubMed Web of Science ®Google Scholar
• Dhawan S, Varma M, Sinha V. 2005. High molecular weight poly (ethylene oxide)-based drug delivery systems. Pharm Technol. 29(5):72–80.
   Google Scholar
• Djuris J, Medarevic D, Krstic M, Djuric Z, Ibric S. 2013. Application of quality by design concepts in the development of fluidized bed granulation and tableting processes. J Pharm Sci. 102(6):1869–1882.
   PubMed Web of Science ®Google Scholar
• Donbrow M. 1987. Stability of the polyoxyethylene chain. Nonionic Surfactants: Phys Chem. 23:1011–1067.
   Google Scholar
• Dow technical data, POLYOX Water granulation with POLYOX WSR. 2003.
   Google Scholar
• Dow, using dow excipients for controlled release of drugs in hydrophilic matrix systems, The Dow Chemical Company, USA. 2006.
   Google Scholar
• Dust Explosibility. 2002. Technical Data. POLYOX Water-Soluble Resins. Midland, MI: Dow Chemical Company.
   Google Scholar
• Efentakis M, Iliopoyloy A, Siamidi A. 2011. Effect of core size and excipients on the lag time and drug release from a pulsatile drug delivery system. Drug Dev Ind Pharm. 37(1):113–120.
   PubMed Web of Science ®Google Scholar
• El-Malah Y, Nazzal S. 2006. Hydrophilic matrices: application of Placket–Burman screening design to model the effect of POLYOX–carbopol blends on drug release. Int J Pharm. 309(1–2):163–170.
   PubMed Web of Science ®Google Scholar
• El-Gazayerly ON, Rakkanka V, Ayres JW. 2004. Novel chewable sustained-release tablet containing verapamil hydrochloride. Pharm Dev Technol. 9(2):181–188.
   PubMed Web of Science ®Google Scholar
• Elzayat EM, Abdel-Rahman AA, Ahmed SM, Alanazi FK, Habib WA, Sakr A. 2016. Studying the impact of formulation and processing parameters on the release characteristics from hydroxypropyl methylcellulose matrix tablets of diclofenac. Acta Pol Pharm. 73(2):439–452.
   PubMed Web of Science ®Google Scholar
• Food U, Administration D. 2015. Information for healthcare professionals: hydromorphone hydrochloride extended-release capsules (marketed as Palladone).
   Google Scholar
• Fuertes I, Caraballo I, Miranda A, Millán M. 2010. Study of critical points of drugs with different solubilities in hydrophilic matrices. Int J Pharm. 383(1–2):138–146.
   PubMedGoogle Scholar
• Gad SC. 2008. Pharmaceutical manufacturing handbook: production and processes. Vol. 5. New York: John Wiley & Sons.
   Google Scholar
• Gao P, Skoug JW, Nixon PR, Robert Ju T, Stemm NL, Sung KC. 1996. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release. J Pharm Sci. 85(7):732–740.
   PubMed Web of Science ®Google Scholar
• Garg S, Bhatia M, Kumar P. 2009. Effect of different polyoxyethylene matrices on extended release formulation of cephalexin trihydrate. Res J Pharm Dosage Forms Technol. 1(3):269–274.
   Google Scholar
• Gharti K, Budhathoki U, Thapa P, Bhargava A. 2012. Formulation and in vitro evaluation of floating tablets of hydroxypropyl methylcellulose and polyethylene oxide using ranitidine hydrochloride as a model drug. J Young Pharm. 4(4):201–208.
   PubMedGoogle Scholar
• Ghori MU, Conway BR. 2015. Hydrophilic matrices for oral control drug delivery. Am J Pharmacol Sci. 3(5):103–109.
   Google Scholar
• Gohel M, Patel M, Amin A, Agrawal R, Dave R, Bariya N. 2004. Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique. AAPs PharmSciTech. 5(3):10–15.
   Web of Science ®Google Scholar
• Guerra-Ponce WL, Gracia-Vásquez SL, González-Barranco P, Camacho-Mora IA, Gracia-Vásquez YA, Orozco-Beltrán E, Felton LA. 2016. In vitro evaluation of sustained released matrix tablets containing ibuprofen: a model poorly water-soluble drug. Braz J Pharm Sci. 52(4):751–759.
   Web of Science ®Google Scholar
• Gupta CR, Kishore GK, Ratna JV. 2013. Development and evaluation of aceclofenac matrix tablets using polyethylene oxides as sustained release polymers. J Pharm Res. 6(2):249–254.
   Google Scholar
• Gupta P, Monteith D. 2016. Sustained release formulation and tablets prepared therefrom. Google patents.
   Google Scholar
• He Yuantian LS, Dajian Y, Xinzi C. 2011. Colchicine framework controlled release tablets or capsules. Google patents.
   Google Scholar
• Herting MG, Kleinebudde P. 2008. Studies on the reduction of tensile strength of tablets after roll compaction/dry granulation. Eur J Pharm Biopharm. 70(1):372–379.
   PubMed Web of Science ®Google Scholar
• Herzberger J, Niederer K, Pohlit H, Seiwert J, Worm M, Wurm FR, Frey H. 2016. Polymerization of ethylene oxide, propylene oxide, and other alkylene oxides: synthesis, novel polymer architectures, and bioconjugation. Chem Rev. 116(4):2170–2243.
   PubMed Web of Science ®Google Scholar
• Hiremath P, Saha R. 2008. Oral controlled release formulations of rifampicin. Part II: effect of formulation variables and process parameters on in vitro release. Drug Deliv. 15(3):159–168.
   PubMed Web of Science ®Google Scholar
• Howard MA, Neau SH, Sack MJ. 2006. PEO and MPEG in high drug load extruded and spheronized beads that are devoid of MCC. Int J Pharm. 307(1):66–76.
   PubMedGoogle Scholar
• Huang H, Nguyen P, Inbasekaran P. 2002. Effect of PEO particle size distribution on CR tablets by direct compression method. AAPS Poster.
   Google Scholar
• Huang HH. 2014. Encased tamper resistant controlled release dosage forms. Google patents.
   Google Scholar
• Huang X, Brazel CS. 2001. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release. 73(2–3):121–136.
   PubMed Web of Science ®Google Scholar
• Ian BR, Della Cruz GW, Goldson F, Kalorak M, Maliki VM, Iye G, Mapirella AF, Pal JS, Sidlin RA, Stagner,  et al. 2012. Sustained release formulations comprising lamotrigine. Google patents.
   Google Scholar
• Iffat W, Shoaib MH, Yousuf RI. 2017. Hydrophillic and hydrophobic polymer combination: formulation development and optimatization of nicorandil sustained release tablet. Lat Am J Pharm. 36(5):907–917.
   Web of Science ®Google Scholar
• Iqubal MK, Singk P, Shuaib M, Singh M. 2014. Recent advances in direct compression technique for Pharmaceutical tablet formulation. Int J Pharm Res Dev. 6(1):49–57.
   Google Scholar
• Jannat E, Arif AA, Hasan MM, Zarziz AB, Rashid HA. 2016. Granulation techniques & its updated modules. Pharma Innov. 5(10):134–141.
   Google Scholar
• Jedinger N, Khinast J, Roblegg E. 2014. The design of controlled-release formulations resistant to alcohol-induced dose dumping-a review. Eur J Pharm Biopharm. 87(2):217–226.
   PubMed Web of Science ®Google Scholar
• Jeon I, Gilli T, Betz G. 2011. Evaluation of roll compaction as a preparation method for hydroxypropyl cellulose-based matrix tablets. J Pharm Bioallied Sci. 3(2):213–220.
   PubMedGoogle Scholar
• Jhon MS, Andrade JD. 1973. Water and hydrogels. J Biomed Mater Res. 7(6):509–522.
   PubMed Web of Science ®Google Scholar
• Jin S-J, Yoo Y-H, Kim M-S, Kim J-S, Park J-S, Hwang S-J. 2008. Paroxetine hydrochloride controlled release POLYOX matrix tablets: screening of formulation variables using Plackett-Burman screening design. Arch Pharm Res. 31(3):399–405.
   PubMed Web of Science ®Google Scholar
• Jivraj M, Martini LG, Thomson CM. 2000. An overview of the different excipients useful for the direct compression of tablets. Pharm Sci Technol Today. 3(2):58–63.
   PubMedGoogle Scholar
• Kaialy W, Bello H, Asare‐Addo K, Nokhodchi A. 2016. Effect of solvent on retarding the release of diltiazem HCl from Polyox-based liquisolid tablets. J Pharm Pharmacol. 68(11):1396–1402.
   PubMed Web of Science ®Google Scholar
• Kaur G, Grewal J, Jyoti K, Jain UK, Chandra R, Madan J. 2018. Oral controlled and sustained drug delivery systems: concepts, advances, preclinical, and clinical status. Drug Targeting and Stimuli Sensitive Drug Delivery Systems. New York: Elsevier; p. 567–626.
   Google Scholar
• Kavugoli N, Narayanaswamy V. 2016. Formulation and evaluation of controlled release matrix tablets of labetalol HCl. Asian J Pharm Res. 6(2):107–120.
   Google Scholar
• Kesarla RS, Vora PA, Sridhar B, Patel G, Omri A. 2015. Formulation and evaluation of floating tablet of H2-receptor antagonist. Drug Dev Ind Pharm. 41(9):1499–1511.
   PubMed Web of Science ®Google Scholar
• Khan GM, Jiabi Z. 1998. Formulation and in vitro evaluation of ibuprofen-carbopol® 974P-NF controlled release matrix tablets III: influence of co-excipients on release rate of the drug. J Control Release. 54(2):185–190.
   PubMed Web of Science ®Google Scholar
• Kim C-J. 1998. Effects of drug solubility, drug loading, and polymer molecular weight on drug release from Polyox tablets. Drug Dev Ind Pharm. 24(7):645–651.
   PubMed Web of Science ®Google Scholar
• Kim CJ. 1999. Release kinetics of coated, donut-shaped tablets for water soluble drugs. Eur J Pharm Sci. 7(3):237–242.
   PubMed Web of Science ®Google Scholar
• Kim CJ. 1995. Drug release from compressed hydrophilic POLYOX-WSR tablets. J Pharm Sci. 84(3):303–306.
   PubMed Web of Science ®Google Scholar
• Kim H-J, Fassihi R. 2001. A ternary polymeric matrix system for controlled drug delivery of highly soluble drug with high drug loading: diltiazem hydrochloride. J Pharm Investig. 31(1):19–25.
   Google Scholar
• Kim H, Fassihi R. 1997. A new ternary polymeric matrix system for controlled drug delivery of highly soluble drugs: I. Diltiazem hydrochloride. Pharm Res. 14(10):1415–1421.
   PubMed Web of Science ®Google Scholar
• Kojima H, Yoshihara K, Sawada T, Kondo H, Sako K. 2008. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets. Eur J Pharm Biopharm. 70(2):556–562.
   PubMed Web of Science ®Google Scholar
• Körner A, Larsson A, Andersson Å, Piculell L. 2010. Swelling and polymer erosion for poly(ethylene oxide) tablets of different molecular weights polydispersities. J Pharm Sci. 99(3):1225–1238.
   PubMed Web of Science ®Google Scholar
• Körner A, Larsson A, Piculell L, Wittgren B. 2005a. Molecular information on the dissolution of polydisperse polymers: mixtures of long and short poly(ethylene oxide)). J Phys Chem B. 109(23):11530–11537.
   PubMed Web of Science ®Google Scholar
• Körner A, Larsson A, Piculell L, Wittgren B. 2005b. Tuning the polymer release from hydrophilic matrix tablets by mixing short and long matrix polymers. J Pharm Sci. 94(4):759–769.
   PubMed Web of Science ®Google Scholar
• Körner A, Piculell L, Iselau F, Wittgren B, Larsson A. 2009. Influence of different polymer types on the overall release mechanism in hydrophilic matrix tablets. Molecules. 14(8):2699–2716.
   PubMed Web of Science ®Google Scholar
• Košir D, Vrečer F. 2017. The performance of HPMC matrix tablets using various agglomeration manufacturing processes. Drug Dev Ind Pharm. 43(2):329–337.
   PubMed Web of Science ®Google Scholar
• Krajacic A, Tucker IG. 2003. Matrix formation in sustained release tablets: possible mechanism of dose dumping. Int J Pharm. 251(1–2):67–78.
   PubMedGoogle Scholar
• Krekeler A, Neumann D, Sedlmayr M. 2019. Pharmaceutical composition of vortioxetine hydrobromide comprising vortioxetine hydrobromide in a polyethylene oxide matrix. Google patents.
   Google Scholar
• Krögel I, Bodmeier R. 1999. Development of a multifunctional matrix drug delivery system surrounded by an impermeable cylinder. J Control Release. 61(1–2):43–50.
   PubMed Web of Science ®Google Scholar
• Kumar V, McGuffy KS. 2001. Methods and formulations for making bupropion hydrochloride tablets using direct compression. Google patents.
   Google Scholar
• L’Hote-Gaston J, Schmitt R, Levina M, Wen G, Rajabi-Siahboomi A. 2009. The use of polyethylene oxide mixtures to study formulation robustness in hydrophilic extended release matrix tablets. AAPS Poster.
   Google Scholar
• L'Hote-Gaston J, Wallick D, 2008. Effect of filler type on the stability of polyethylene oxide in a hydrophilic matrix tablet. Poster session presented at: 35th Annual Meeting and Exposition of the Controlled Release Society; Jul 12–16; New York, USA.
   Google Scholar
• Li CL, Martini LG, Ford JL, Roberts M. 2005. The use of hypromellose in oral drug delivery. J Pharm Pharmacol. 57(5):533–546.
   PubMed Web of Science ®Google Scholar
• Li H, Gu X. 2007. Correlation between drug dissolution and polymer hydration: a study using texture analysis. Int J Pharm. 342(1–2):18–25.
   PubMedGoogle Scholar
• Li H, Hardy RJ, Gu X. 2008. Effect of drug solubility on polymer hydration and drug dissolution from polyethylene oxide (PEO) matrix tablets. AAPS PharmSciTech. 9(2):437–443.
   PubMed Web of Science ®Google Scholar
• Li J, Luo C, Zhang D, Li M, Fu Q, He Z. 2016. Formulation and development of ternary hybrid matrix tablets of diltiazem hydrochloride. Powder Technol. 294:66–70.
   Web of Science ®Google Scholar
• Liu K, Wu Y. 2016. Sustained-release preparation of ivabradine or pharmaceutically acceptable salts thereof. Google patents.
   Google Scholar
• Lotfipour F, Nokhodchi A, Saeedi M, Norouzi-Sani S, Sharbafi J, Siahi-Shadbad M. 2004. The effect of hydrophilic and lipophilic polymers and fillers on the release rate of atenolol from HPMC matrices. Farmaco. 59(10):819–825.
   PubMedGoogle Scholar
• Ma L, Deng L, Chen J. 2014. Applications of poly(ethylene oxide) in controlled release tablet systems: a review. Drug Dev Ind Pharm. 40(7):845–851.
   PubMed Web of Science ®Google Scholar
• Maclaine J, Booth C. 1975. Effect of molecular weight on crystallization isotherms of high molecular weight poly (ethylene oxide) fractions. Polymer. 16(9):680–684.
   Web of Science ®Google Scholar
• Maderuelo C, Zarzuelo A, Lanao JM. 2011. Critical factors in the release of drugs from sustained release hydrophilic matrices. J Control Release. 154(1):2–19.
   PubMed Web of Science ®Google Scholar
• Maggi L, Segale L, Torre M, Machiste EO, Conte U. 2002. Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for the controlled release of a water-soluble drug. Dimensionality study. Biomaterials. 23(4):1113–1119.
   PubMed Web of Science ®Google Scholar
• Mandhar P, Joshi G. 2015. Development of sustained release drug delivery system: a review. Asian Pac J Health Sci. 2(1):179–185.
   Google Scholar
• Martin LM, Rajabi-Siahboomi AR. 2014. Applications of polyethylene oxide (POLYOX) in hydrophilic matrices. Hydrophilic Matrix Tablets for Oral Controlled Release. New York: Springer; p. 123–141.
   Google Scholar
• Medarevic D, Krstic M, Stankovic S, Grujic B, Ibric S. 2012. Polyethylene oxides as matrix forming agents: direct compression vs. wet granulation. In Rantanen J, Naelapää K, He J, editors. Proceedings of the 2nd Electronic Conference on Pharmaceutical Sciences (ECPS 2012); May 1–31; MDPI. p. 1–17.
   Google Scholar
• Meka VS, Dharmanlingam SR, Kolapalli VRM. 2014. Formulation of gastroretentive floating drug delivery system using hydrophilic polymers and its in vitro characterization. Braz J Pharm Sci. 50(2):431–439.
   Web of Science ®Google Scholar
• Meyer RJ. Hussain As. 2005. FDA’s ACPS meeting, Awareness topic: mitigating the risks of ethanol induced dose dumping from oral sustained/controlled release dosage forms. US Food and Drug Administration; [accessed 2019 December, 02]. http://www.fda.gov/ohrms/dockets/ac/05/briefing/2005-4187B1_01_08-Alcohol-Induced. pdf.
   Google Scholar
• Missaghi S, Patel P, Farrell TP, Huatan H, Rajabi-Siahboomi AR. 2014. Investigation of critical core formulation and process parameters for osmotic pump oral drug delivery. AAPS PharmSciTech. 15(1):149–160.
   PubMed Web of Science ®Google Scholar
• Mitchell K, Ford J, Armstrong D, Elliott P, Rostron C, Hogan J. 1993. The influence of concentration on the release of drugs from gels and matrices containing Methocel®. Int J Pharm. 100(1–3):155–163.
   Google Scholar
• Mittal B. 2016. How to develop Robust solid oral dosage forms: from conception to post-approval. London: Academic Press.
   Google Scholar
• Mondal N. 2018. The role of matrix tablet in drug delivery system. Int J App Pharm. 10(1):1–6.
   Google Scholar
• Moroni A, Ghebre-Sellassie I. 1995. Application of poly (oxyethylene) homopolymers in sustained release solid formulations. Drug Dev Ind Pharm. 21(12):1411–1428.
   Web of Science ®Google Scholar
• Nagendrakumar D, Keshavshetti G, Shardor A. 2013. An overview: matrix tablets as sustained release. Recent Res Sci Technol. 5(4):36–45.
   Google Scholar
• Nikolić ND, Medarević ĐP, Ibrić SR, Đurić ZR. 2015. Evaluation of formulation and effects of process parameters on drug release and mechanical properties of tramadol hydrocloride sustained release matrix tablets. Hemijska Industrija. 69(5):503.
   Web of Science ®Google Scholar
• Nokhodchi A, Raja S, Patel P, Asare-Addo K. 2012. The role of oral controlled release matrix tablets in drug delivery systems. BioImpacts: BI. 2(4):175.
   PubMedGoogle Scholar
• Oliveira PR, Mendes C, Klein L, Sangoi MS, Bernardi LS, Silva MAS. 2013. Formulation development and stability studies of norfloxacin extended-release matrix tablets. BioMed Res Int. 2013:1–9.
   Web of Science ®Google Scholar
• Palmer D, Levina M, Rajabi-Siahboomi AR. 2008. The influence of in vitro dissolution method on the release of a highly water soluble drug from polyethylene oxide and hypromellose hydrophilic extended release matrices. Poster session presented at: AAPS annual meeting and exposition; Nov 16–20; Atlanta, USA.
   Google Scholar
• Palmer D, Levina M, Douroumis D, Maniruzzaman M, Morgan DJ, Farrell TP, Rajabi-Siahboomi AR, Nokhodchi A. 2013. Mechanism of synergistic interactions and its influence on drug release from extended release matrices manufactured using binary mixtures of polyethylene oxide and sodium carboxymethylcellulose. Colloids Surf B Biointerfaces. 104:174–180.
   PubMed Web of Science ®Google Scholar
• Palmer D, Levina M, Farrell TP, Rajabi-Siahboomi A. 2011a. The influence of hydro-alcoholic media on drug release from polyethylene oxide extended-release matrix tablets. Pharm Technol. 35(7):50–58.
   Google Scholar
• Palmer D, Levina M, Nokhodchi A, Douroumis D, Farrell T, Rajabi-Siahboomi A. 2011b. The influence of sodium carboxymethylcellulose on drug release from polyethylene oxide extended release matrices. AAPS PharmSciTech. 12(3):862–871.
   PubMed Web of Science ®Google Scholar
• Park JS, Shim JY, Park JS, Choi YW, Jeong SH. 2011. A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles. Drug Dev Ind Pharm. 37(6):664–672.
   PubMed Web of Science ®Google Scholar
• Patel K, Gohel MC. 2012. Formulation development of isoxsuprine hydrochloride modified release matrix tablets. Int J Pharm Sci Res. 3(1):218.
   Google Scholar
• Patel P, Missaghi S, Farrell TP, Rajabi-Siahboomi AR. 2012. Effect of granulation processing parameters on performance of push-pull osmotic pump tablets of a practically water insoluble model drug. Poster session presented at: 39th Annual Meeting & Exposition of the Controlled Release Society; July 15–18; Quebec City, Canada.
   Google Scholar
• Pena AF, Backers OPH, Calzada JV. 2019. Modified release tablet composition comprising mirabegron. Google Patents.
   Google Scholar
• Pharma & Food Solutions. 2013. POLYOX^TM Water Soluble Resins Combining Flexibility with Consistency. Midland, MI: Dow Chemical Company Brochure.
   Google Scholar
• Physico-mechanical Characterization of POLYOX™ for Tablet Manufacture. Application Data. PolyoxTM Water soluble Resins. Colorcon; 2009.
   Google Scholar
• Pilgaonkar PS, Rustomjee MT. Gandhi AS. 2015. Controlled release pharmaceutical formulations of direct thrombin inhibitors. Google patents.
   Google Scholar
• Pillay V, Fassihi R. 1999. Electrolyte-induced compositional heterogeneity: a novel approach for rate-controlled oral drug delivery. J Pharm Sci. 88(11):1140–1148.
   PubMed Web of Science ®Google Scholar
• Pillay V, Fassihi R. 2001. Probing the dynamics of matrix hydration in the presence of electrolytes. Drug Deliv. 8(2):87–92.
   PubMed Web of Science ®Google Scholar
• Pinto JF, Wunder KF, Okoloekwe A. 2004. Evaluation of the potential use of poly(ethylene oxide) as tablet- and extrudate-forming material. Aaps J. 6(2):17–26.
   PubMedGoogle Scholar
• POLYOX Water-Soluble Resins NF in Pharmaceutical Applications. 2004. Dow Chemical Company Brochure.
   Google Scholar
• POLYOX Water-soluble Resins NF in Pharmaceutical Applications. Dow Chemical Company Brochure; August 2004.
   Google Scholar
• POLYOX Water-Soluble Resins. 2002. Unique resins for binding, lubricity, adhesion and emollient performance. Midland, MI: Dow Chemical Company Brochure.
   Google Scholar
• Puz MJ, Johnson BA, Murphy BJ. 2005. Use of the antioxidant BHT in asymmetric membrane tablet coatings to stabilize the core to the acid catalyzed peroxide oxidation of a thioether drug. Pharm Dev Technol. 10(1):115–125.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Chen Y, Zhang GG, Yu L, Mantri RV. 2016. Developing solid oral dosage forms: pharmaceutical theory and practice. London: Academic Press.
   Google Scholar
• Rajabi-Siahboomi A, Bowtell R, Mansfield P, Henderson A, Davies M, Melia C. 1994. Structure and behaviour in hydrophilic matrix sustained release dosage forms: 2. NMR-imaging studies of dimensional changes in the gel layer and core of HPMC tablets undergoing hydration. J Control Release. 31(2):121–128.
   Web of Science ®Google Scholar
• Ramani C, Wang J, Kane A, Chow K, Lambing J. 2013. Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low pH and methods of use thereof. Google patents.
   Google Scholar
• Rane M, Parmar J, Siahboomi A. 2010. Hydrophilic matrices for oral extended release: influence of fillers on drug release from HPMC matrices. Pharma Times. 42(04):41–45.
   Google Scholar
• Rane M, Parmar J, Tiwari S, Rajabi-Siahboomi A. 2013. Application of polyethylene oxide in hydrophilic matrix tablets. Pharma Times. 45(3):41–48.
   Google Scholar
• Ravi PR, Ganga S, Saha RN. 2008. Design and in vitro evaluation of zidovudine oral controlled release tablets prepared using hydroxypropyl methylcellulose. Chem Pharm Bull. 56(4):518–524.
   PubMed Web of Science ®Google Scholar
• Reddy KR, Mutalik S, Reddy S. 2003. Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation. AAPS Pharmscitech. 4(4):480–488.
   Google Scholar
• Reza MS, Quadir MA, Haider SS. 2003. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery. J Pharm Pharm Sci. 6(2):282–291.
   PubMed Web of Science ®Google Scholar
• Rod Ball LX, Yinghuan L. 2009. Hard-soluble medicine release-controlled formulation, Google patents.
   Google Scholar
• Rowe RC, Sheskey P, Quinn M. 2009. Handbook of pharmaceutical excipients. London: Libros Digitales-Pharmaceutical Press.
   Google Scholar
• Rowe RC, Sheskey PJ, Owen SC. 2006. Handbook of pharmaceutical excipients. Vol. 1. London: Pharmaceutical Press.
   Google Scholar
• Rushing TS, Hester RD. 2003. Intrinsic viscosity dependence on polymer molecular weight and fluid temperature. J Appl Polym Sci. 89(10):2831–2835.
   Web of Science ®Google Scholar
• Salsa T, Veiga F, Pina M. 1997. Oral controlled-release dosage forms. I. Cellulose ether polymers in hydrophilic matrices. Drug Dev Ind Pharm. 23(9):929–938.
   Web of Science ®Google Scholar
• Saltel DA, Vachon M. 2014. Controlled release formulations of lorazepam. Google patents.
   Google Scholar
• Sanjeevani D, Madhavi P, Ajinath S, Satish S. 2013. Development of sustained release tablet of Mebeverine hydrochloride. J Pharm Educ Res. 4(1): 64–70.
   Google Scholar
• Sasidhar R, Vidyadhara S, Nagaraju R. 2011. Effect of diluents on the release rate of venlafaxine Hcl from matrix tablets. J Pharm Res. 4(1):153–155.
   Google Scholar
• Schmitt RL, Chien C, Shrestha U. 2004. Polyethylene oxide matrix tablets prepared by roller compaction. Poster session presented at: AAPS annual meeting and exposition; Nov 7–11; Baltimore, Maryland.
   Google Scholar
• Sedmak Gregor SM. inventor. 26 May. 2010. Pharmaceutical composition comprising tamsulosin. Patent WO 2010/136193 Al.
   Google Scholar
• Seth P. 2004. Solid composition containing nisoldipine a mixture of polyethylene oxides and an antioxidant. Google patents.
   Google Scholar
•  Setti MV, Ratna JV. 2014. Preparation and evaluation of controlled release tablets of carvedilol. Asian J Pharm. 3(3):252–256.
   Google Scholar
• Shah KR, Chaudhary SA, Mehta TA. 2014. Polyox (polyethylene oxide) multifunctional polymer in novel drug delivery system. Int J Pharm Sci Drug Res. 6(2):95–101.
   Google Scholar
• Shah R, Patel S, Patel H, Pandey S, Shah S, Shah D. 2013. Formulation development of carvedilol compression coated tablet. Pharm Dev Technol. 18(4):906–915.
   PubMed Web of Science ®Google Scholar
• Shah S, Shukla D, Pandey H. 2019. Formulation optimization of polyox based modified release drug delivery system. J Drug Deliv Ther. 9(4s):551–561.
   Google Scholar
• Shahi S, Sonawane A, Vanamore S, Zadbuke N. 2013. Formulation and in-vitro characterization of acyclovir floating matrix tablets: a factorial design study. J Appl Pharm Sci. 3(5):65–74.
   Google Scholar
• Shanmugam S. 2015. Granulation techniques and technologies: recent progresses. Bioimpacts. 5(1):55–63.
   PubMed Web of Science ®Google Scholar
• Shojaee S, Asare-Addo K, Kaialy W, Nokhodchi A, Cumming I. 2013. An investigation into the stabilization of diltiazem HCl release from matrices made from aged polyox powders. AAPS PharmSciTech. 14(3):1190–1198.
   PubMed Web of Science ®Google Scholar
• Shojaee S, Emami P, Mahmood A, Rowaiye Y, Dukulay A, Kaialy W, Cumming I, Nokhodchi A. 2015a. An investigation on the effect of polyethylene oxide concentration and particle size in modulating theophylline release from tablet matrices. AAPS PharmSciTech. 16(6):1281–1289.
   PubMed Web of Science ®Google Scholar
• Shojaee S, Kaialy W, Cumming KI, Nokhodchi A. 2016. Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type. Pharm Dev Technol. 21(2):189–195.
   PubMed Web of Science ®Google Scholar
• Shojaee S, Nokhodchi A, Cumming I, Alhalaweh A, Kaialy W. 2015b. Investigation of drug release from PEO tablet matrices in the presence of vitamin E as antioxidant. Curr Drug Deliv. 12(5):591–599.
   PubMed Web of Science ®Google Scholar
• Shojaee S, Nokhodchi A, Maniruzzaman M. 2017. Evaluation of the drug solubility and rush ageing on drug release performance of various model drugs from the modified release polyethylene oxide matrix tablets. Drug Deliv Transl Res. 7(1):111–124.
   PubMed Web of Science ®Google Scholar
• Siepmann J, Ainaoui A, Vergnaud J, Bodmeier R. 1998. Calculation of the dimensions of drug-polymer devices based on diffusion parameters. J Pharm Sci. 87(7):827–832.
   PubMed Web of Science ®Google Scholar
• Siepmann J, Kranz H, Bodmeier R, Peppas N. 1999a. HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics. Pharm Res. 16(11):1748–1756.
   PubMed Web of Science ®Google Scholar
• Siepmann J, Kranz H, Peppas N, Bodmeier R. 2000. Calculation of the required size and shape of hydroxypropyl methylcellulose matrices to achieve desired drug release profiles. Int J Pharm. 201(2):151–164.
   PubMed Web of Science ®Google Scholar
• Siepmann J, Podual K, Sriwongjanya M, Peppas N, Bodmeier R. 1999b. A new model describing the swelling and drug release kinetics from hydroxypropyl methylcellulose tablets. J Pharm Sci. 88(1):65–72.
   PubMed Web of Science ®Google Scholar
• Sisinthy S, Rao N, Rao M. 2015. Controlled release layered matrix tablets of itopride hydrochloride: in vitro and in vivo evaluation. Asian J Pharm Clin Res. 8(6):130–135.
   Google Scholar
• Skoug JW, Borin MT, Fleishaker JC, Cooper AM. 1991. In vitro and in vivo evaluation of whole and half tablets of sustained-release adinazolam mesylate. Pharm Res. 8(12):1482–1488.
   PubMed Web of Science ®Google Scholar
• Souza DFd, Goebel K, Andreazza IF. 2013. Development of enteric coated sustained release minitablets containing mesalamine. Braz J Pharm Sci. 49(3):529–536.
   Web of Science ®Google Scholar
• Streubel A, Siepmann J, Bodmeier R. 2003. Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release. Eur J Pharm Sci. 18(1):37–45.
   PubMed Web of Science ®Google Scholar
• Tadokoro H, Chatani Y, Yoshihara T, Tahara S, Murahashi S. 1964. Structural studies on polyethers,[‐(CH2) m‐O‐] n. II. Molecular structure of polyethylene oxide. Makromol Chem. 73(1):109–127.
   Google Scholar
• Talukdar MM, Michoel A, Rombaut P, Kinget R. 1996. Comparative study on xanthan gum and hydroxypropylmethyl cellulose as matrices for controlled-release drug delivery I. Compaction and in vitro drug release behaviour. Int J Pharm. 129(1–2):233–241.
   Google Scholar
• Teng Y, Qiu Z, Wen H. 2009. Systematical approach of formulation and process development using roller compaction. Eur J Pharm Biopharm. 73(2):219–229.
   PubMed Web of Science ®Google Scholar
• Thakur VK, Thakur MK. 2016. Handbook of sustainable polymers: structure and chemistry. Singapore: Jenny Stanford Publishing.
   Google Scholar
• The Influence of In Vitro Dissolution Method on the Release of a Highly Water Soluble Drug from Polyethylene Oxide and Hypromellose Hydrophilic Extended Release Matrices 2010. POLYOX™ Water Soluble Resins, Application Data.
   Google Scholar
• Thumma S, Majumdar S, ElSohly MA, Gul W, Repka MA. 2008. Chemical stability and bioadhesive properties of an ester prodrug of Delta 9-tetrahydrocannabinol in poly(ethylene oxide) matrices: effect of formulation additives. Int J Pharm. 362(1–2):126–132.
   PubMedGoogle Scholar
• Timmins P, Pygall SR, Melia CD. 2014. Hydrophilic matrix tablets for oral controlled release. Vol. 55. New York: Springer.
   Google Scholar
• Tiwari SB, Rajabi-Siahboomi AR. 2008. Extended-release oral drug delivery technologies: monolithic matrix systems. Drug delivery systems. New York: Springer; p. 217–243.
   Google Scholar
• Tiwari SB, Rajabi-Siahboomi AR. 2009. Applications of complementary polymers in HPMC hydrophilic extended release matrices. Drug Deliv Technol. 9(7):20–27.
   Google Scholar
• Tysak T. 2015. Low gloss aqueous coating compositions containing poly (ethylene oxide). Google patents.
   Google Scholar
• U.S. Food and Drug Administration Inactive Ingredients Database. October, 2019.
   Google Scholar
• U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202611s000lbl.pdf
   Google Scholar
• U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/200533s014lbl.pdf
   Google Scholar
• U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205879s000lbl.pdf
   Google Scholar
• U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208658s001lbl.pdf
   Google Scholar
• U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209501s000lbl.pdf
   Google Scholar
• U.S. Food and Drug Administration [accessed]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022272s040s041lbl.pdf
   Google Scholar
• U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206627s007s008lbl.pdf
   Google Scholar
• Ummadi S, Shravani B, Rao N, Reddy MS, Sanjeev B. 2013. Overview on controlled release dosage form. System. 7(8):51–60.
   Google Scholar
• Upadhyay P, Nayak K, Patel K, Patel J, Shah S, Deshpande J. 2014. Formulation development, optimization, and evaluation of sustained release tablet of valacyclovir hydrochloride by combined approach of floating and swelling for better gastric retention. Drug Deliv Transl Res. 4(5–6):452–464.
   PubMed Web of Science ®Google Scholar
• Upadhye SB, Rajabi-Siahboomi AR. 2013. Properties and applications of polyethylene oxide and ethylcellulose for tamper resistance and controlled drug delivery. Melt Extrusion. New York: Springer; p. 145–158.
   Google Scholar
• Vernengo AJ, Kadlowec J, Kubinski P, Tulenko TN, Iftode C, Johnson B, Wiltsey C. 2016. Self-assembling biomimetic hydrogels having bioadhesive properties. Google patents.
   Google Scholar
• Vidyadhara S, Sasidhar R, Nagaraju R. 2013. Design and development of polyethylene oxide based matrix tablets for verapamil hydrochloride. Indian J Pharm Sci. 75(2):185–190.
   PubMed Web of Science ®Google Scholar
• Viswanathan P, Muralidaran Y, Ragavan G. 2017. Challenges in oral drug delivery: a nano-based strategy to overcome. Nanostructures for Oral Medicine. New York: Elsevier; p. 173–201.
   Google Scholar
• Vrbanac H, Krese A. 2019. The influence of different mechanical stress on the release properties of HPMC matrix tablets in sucrose-NaCl media. J Drug Deliv Sci Technol. 54:101246.
   Web of Science ®Google Scholar
• Wan L, Heng P, Wong L. 1991. The effect of hydroxypropylmethylcellulose on water penetration into a matrix system. Int J Pharm. 73(2):111–116.
   Google Scholar
• Water soluble-resin storage stability, Technical data, POLYOX water soluble resins, The DOW Chemical Company; 2004.
   Google Scholar
• Wen H, Li X, Li Y, Wang H, Wang Y, Wang T, Pan W, Yang X. 2018. In vitro and in vivo evaluation of controlled-release matrix tablets of highly water-soluble drug applying different mw polyethylene oxides (PEO) as retardants. Drug Dev Ind Pharm. 44(4):544–552.
   PubMed Web of Science ®Google Scholar
• Wen H, Park K. 2011. Oral controlled release formulation design and drug delivery: theory to practice. New York: John Wiley & Sons.
   Google Scholar
• Woo J-H, Na W-S, Jeong Y-S, Hyun C-K, Park Y-S. 2018. Sustained release tablet comprising pregabalin through two-phase release-controlling system. Google patents.
   Google Scholar
• Yang L, Johnson B, Fassihi R. 1998. Determination of continuous changes in the gel layer thickness of poly(ethylene oxide) and HPMC tablets undergoing hydration: a texture analysis study. Pharm Res. 15(12):1902–1906.
   PubMed Web of Science ®Google Scholar
• Yang L, Venkatesh G, Fassihi R. 1996. Characterization of compressibility and compactibility of poly(ethylene oxide) polymers for modified release application by compaction simulator. J Pharm Sci. 85(10):1085–1090.
   PubMed Web of Science ®Google Scholar
• Yin X, Li H, Guo Z, Wu L, Chen F, de Matas M, Shao Q, Xiao T, York P, He Y, et al. 2013. Quantification of swelling and erosion in the controlled release of a poorly water-soluble drug using synchrotron X-ray computed microtomography. AAPS J. 15(4):1025–1034.
   PubMed Web of Science ®Google Scholar
• Yu X, Lawrence XY, Teng Y, Gaglani DK, Rege BD, Rosencrance S. 2019. Implementation of pharmaceutical quality by design in wet granulation. Handbook of pharmaceutical wet granulation. New York: Elsevier; p. 703–733.
   Google Scholar
• Zhang F, Meng F, Lubach J, Koleng J, Watson N. 2016. Properties and mechanisms of drug release from matrix tablets containing poly(ethylene oxide) and poly(acrylic acid) as release retardants. Eur J Pharm Biopharm. 105:97–105.
   PubMed Web of Science ®Google Scholar